News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
711,019 Results
Type
Article (42102)
Company Profile (294)
Press Release (668623)
Section
Business (210267)
Career Advice (2086)
Deals (36610)
Drug Delivery (101)
Drug Development (82927)
Employer Resources (172)
FDA (16520)
Job Trends (15376)
News (355680)
Policy (33851)
Tag
Academia (2575)
Alliances (51301)
Alzheimer's disease (1320)
Approvals (16487)
Artificial intelligence (205)
Bankruptcy (365)
Best Places to Work (11767)
Biotechnology (188)
Breast cancer (219)
Cancer (1649)
Cardiovascular disease (130)
Career advice (1745)
Cell therapy (332)
Clinical research (66661)
Collaboration (642)
Compensation (354)
COVID-19 (2628)
C-suite (151)
Data (1542)
Diabetes (206)
Diagnostics (6333)
Earnings (86900)
Employer resources (149)
Events (113520)
Executive appointments (549)
FDA (17372)
Funding (574)
Gene therapy (239)
GLP-1 (675)
Government (4473)
Healthcare (18937)
Infectious disease (2733)
Inflammatory bowel disease (119)
Interviews (320)
IPO (16716)
Job creations (4054)
Job search strategy (1489)
Layoffs (455)
Legal (8346)
Lung cancer (246)
Manufacturing (237)
Medical device (13334)
Medtech (13339)
Mergers & acquisitions (20225)
Metabolic disorders (549)
Neuroscience (1724)
NextGen: Class of 2025 (6633)
Non-profit (4524)
Northern California (1977)
Obesity (313)
Opinion (215)
Patents (147)
People (58725)
Phase I (20666)
Phase II (29339)
Phase III (21980)
Pipeline (660)
Postmarket research (2653)
Preclinical (8750)
Radiopharmaceuticals (246)
Rare diseases (320)
Real estate (6245)
Regulatory (22701)
Research institute (2360)
Resumes & cover letters (358)
Southern California (1718)
Startups (3717)
United States (17869)
Vaccines (621)
Weight loss (220)
Date
Today (28)
Last 7 days (638)
Last 30 days (2431)
Last 365 days (35128)
2025 (3351)
2024 (35769)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54794)
2019 (47400)
2018 (35771)
2017 (33138)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (778)
Arizona (215)
Asia (40332)
Australia (6458)
California (4546)
Canada (1646)
China (386)
Colorado (208)
Connecticut (215)
Europe (85928)
Florida (662)
Georgia (158)
Illinois (456)
Indiana (260)
Japan (117)
Maryland (722)
Massachusetts (3533)
Michigan (196)
Minnesota (328)
New Jersey (1299)
New York (1301)
North Carolina (828)
Northern California (1977)
Ohio (164)
Pennsylvania (1063)
South America (1159)
Southern California (1718)
Texas (671)
Utah (139)
Washington State (457)
711,019 Results for "amphastar pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Amphastar Pharmaceuticals, Inc. will participate in an Analyst-Moderated fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 12:30 pm EST.
June 3, 2024
·
4 min read
Press Releases
Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
·
3 min read
Business
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended March 31, 2024.
May 8, 2024
·
14 min read
Biotech Beach
Amphastar Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
Amphastar Pharmaceuticals, Inc. announced that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will participate in an Analyst-Moderated fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 12:30 pm EST.
June 3, 2024
·
4 min read
Biotech Beach
Amphastar Announces Additional $50 Million Increase to its Share Buyback Program
Amphastar Pharmaceuticals, Inc. announced that on June 3, 2024, the Company’s Board of Directors authorized a $50 million increase to the Company’s share buyback program, which is expected to continue for an indefinite period of time.
June 4, 2024
·
4 min read
Press Releases
Amphastar Pharmaceuticals to Present at the 2024 Jefferies London Healthcare Conference
November 14, 2024
·
3 min read
Press Releases
Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference
November 26, 2024
·
3 min read
Biotech Beach
Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Dan Dischner SVP of Corp. Communication, will participate in an Analyst-Moderated fireside chat at the Bank of America Health Care Conference on Wednesday, May 15th, 2024 at 2:20 pm PDT.
May 9, 2024
·
4 min read
FDA
Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has granted approval for the Company’s Abbreviated New Drug Application for Albuterol Sulfate Inhalation Aerosol, previously known as AMP-008.
May 22, 2024
·
5 min read
Business
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the three months and full-year ended December 31, 2023.
February 28, 2024
·
20 min read
1 of 71,102
Next
